RUNX3 and cancer: Another positive biomarker was RUNX3 (selected for 16 cancer types, Figure 3C), which plays a role in the TME regulating hypoxia and immune-cell infiltration, and has been suggested as a potential target to prevent immune escape of cancer cells.62